ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.74
-0.47%
US Tech 100
18,245.95
0.08%
S&P 500
5,320.94
-0.01%
US Dollar vs CAD
1.367
0.21%
Bitcoin
70,117.71
-0.02%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cyclacel Pharmaceuticals Inc (CYCCP)

  7. Cyclacel Pharmaceuticals Inc (CYCCP) News

CYCCP Cyclacel Pharmaceuticals Inc

6.91
-0.08 (-1.14%)
Last Updated: 08:30:02
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cyclacel Pharmaceuticals Inc CYCCP NASDAQ Preference Share
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.08 -1.14% 6.91 08:30:02
Open Price Low Price High Price Close Price Previous Close
6.91 6.91 6.91 6.99
more quote information »

Recent News

Date Time Source Heading
5/17/202408:56EDGAR2Form D - Notice of Exempt Offering of Securities
5/14/202416:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202415:05EDGAR2Form 8-K - Current report
5/14/202415:05GLOBECyclacel Pharmaceuticals Reports First Quarter Financial..
5/13/202415:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/08/202408:15GLOBECyclacel Pharmaceuticals to Release First Quarter 2024..
5/07/202420:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/07/202420:52EDGAR2Form DEF 14A - Other definitive proxy statements
5/06/202416:26EDGAR2Form S-1 - General form for registration of securities under..
5/02/202415:30GLOBECyclacel Pharmaceuticals Announces Closing of $8.0 Million..
4/30/202412:51APS$8 Million Private Placement Announcement Sends Biotech..
4/30/202406:00GLOBECyclacel Pharmaceuticals Announces $8.0 Million Private..
4/01/202408:15GLOBECyclacel Pharmaceuticals to Present New Clinical Data at..
3/19/202415:05GLOBECyclacel Pharmaceuticals Reports Fourth Quarter and Full..
3/13/202415:05GLOBECyclacel Pharmaceuticals to Release Fourth Quarter and Full..
3/07/202408:15GLOBECyclacel Pharmaceuticals Announces Preclinical..
3/06/202408:15GLOBECyclacel Pharmaceuticals Announces Receipt of $2.9 Million..
2/20/202408:15GLOBECyclacel Pharmaceuticals to Participate in 2024 BIO CEO &..
2/14/202415:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/14/202409:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202414:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202416:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202408:15EDGAR2Form 8-K - Current report
1/30/202408:15GLOBECyclacel Pharmaceuticals Announces the Appointment of Brian..
1/19/202415:58EDGAR2Form S-1 - General form for registration of securities under..
1/12/202415:05EDGAR2Form 8-K - Current report
1/10/202412:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/04/202415:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/04/202415:05EDGAR2Form 8-K - Current report
12/26/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202308:29EDGAR2Form 8-K - Current report
12/26/202308:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/18/202308:00GLOBECyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data..
12/12/202315:06EDGAR2Form 8-K - Current report
12/12/202315:05GLOBECyclacel Pharmaceuticals Announces Reverse Stock Split
11/30/202308:15GLOBECyclacel Regains Compliance With Nasdaq Listing Rule..
11/28/202320:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/28/202320:20EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
11/28/202316:15GLOBECyclacel Receives Notification of Deficiency From Nasdaq..
11/28/202315:59EDGAR2Form 8-K - Current report
11/15/202316:04EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
11/15/202316:03EDGAR2Form 8-K - Current report
11/13/202315:06EDGAR2Form 8-K - Current report
11/07/202315:10EDGAR2Form 8-K - Current report
11/07/202308:15GLOBECyclacel Pharmaceuticals to Release Third Quarter 2023..
11/02/202315:30EDGAR2Form PRE 14A - Other preliminary proxy statements
9/08/202315:10EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
CYCCP
Cyclacel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved